AstraZeneca PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other pharmaceutical manufacturers in Europe: Novo Nordisk As of DENMARK (2020 sales of 126.95 billion Danish Kroner [US$20.34 billion] of which 85% was Diabetes and obesity), Sanofi S.A. of FRANCE (37.37 billion Euros [US$44.54 billion] of which 69% was Pharmaceuticals), and Merck KGaA which is based in GERMANY (17.53 billion Euros [US$20.90 billion] of which 43% was Life Science).

Sales Analysis. During the first quarter of 2021, sales at AstraZeneca PLC totalled £5.30 billion. This is an increase of 7.9% from the £4.92 billion in sales at the company during the first quarter of 2020. During the previous 10 quarters, sales at AstraZeneca PLC have increased compared with the same quarter in the previous year. During the year ended December of 2020, sales at AstraZeneca PLC were £20.59 billion (US$28.68 billion). This is an increase of 8.0% versus 2019, when the company's sales were £19.06 billion.